O.V. Miller

1.8k total citations · 1 hit paper
24 papers, 1.4k citations indexed

About

O.V. Miller is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, O.V. Miller has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Cardiology and Cardiovascular Medicine and 8 papers in Molecular Biology. Recurrent topics in O.V. Miller's work include Inflammatory mediators and NSAID effects (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Virus-based gene therapy research (3 papers). O.V. Miller is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers) and Virus-based gene therapy research (3 papers). O.V. Miller collaborates with scholars based in United States. O.V. Miller's co-authors include Robert R. Gorman, S Bunting, Wayne E. Magee, James W. Aiken, Ronald J. Shebuski, Roy A. Johnson, Frank F. Sun, F.A. Fitzpatrick, Seymour Levine and Wendell Wierenga and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Virology.

In The Last Decade

O.V. Miller

24 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

1977 538 citations Robert R. Gorman, O.V. Miller et al. Prostaglandins profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O.V. Miller United States	19	677	448	398	289	252	24	1.4k
J. Casals‐Stenzel Germany	21	184 0.3×	288 0.6×	580 1.5×	97 0.3×	318 1.3×	45	1.4k
I. J. Zeitlin United Kingdom	20	246 0.4×	224 0.5×	344 0.9×	91 0.3×	190 0.8×	65	1.3k
W A Scott United States	17	394 0.6×	53 0.1×	626 1.6×	469 1.6×	372 1.5×	18	1.7k
K. K. F. NG Singapore	10	209 0.3×	440 1.0×	504 1.3×	79 0.3×	158 0.6×	20	1.1k
Emanuel Silverstein United States	23	111 0.2×	350 0.8×	1.0k 2.6×	163 0.6×	253 1.0×	49	1.8k
W C Pickett United States	16	264 0.4×	43 0.1×	468 1.2×	262 0.9×	465 1.8×	28	1.6k
Wanda Cromlish Canada	25	722 1.1×	75 0.2×	925 2.3×	220 0.8×	160 0.6×	34	2.1k
Hugues Chap France	25	118 0.2×	136 0.3×	1.4k 3.5×	180 0.6×	293 1.2×	73	2.5k
William W. Carley United States	23	162 0.2×	96 0.2×	794 2.0×	55 0.2×	247 1.0×	38	1.8k
Zhaohui Ao United States	18	335 0.5×	303 0.7×	608 1.5×	37 0.1×	194 0.8×	28	1.6k

Countries citing papers authored by O.V. Miller

Since Specialization

Citations

This map shows the geographic impact of O.V. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O.V. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O.V. Miller more than expected).

Fields of papers citing papers by O.V. Miller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O.V. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O.V. Miller. The network helps show where O.V. Miller may publish in the future.

Co-authorship network of co-authors of O.V. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of O.V. Miller. A scholar is included among the top collaborators of O.V. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O.V. Miller. O.V. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, O.V., et al.. (1983). The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers. Prostaglandins. 26(2). 287–302. 14 indexed citations

Miller, O.V., Donald E. Ayer, & Robert R. Gorman. (1982). Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 711(3). 445–451. 21 indexed citations

Aiken, James W., Ronald J. Shebuski, O.V. Miller, & Robert R. Gorman. (1981). Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.. Journal of Pharmacology and Experimental Therapeutics. 219(2). 299–308. 103 indexed citations

Miller, O.V., James W. Aiken, Ronald J. Shebuski, & Robert R. Gorman. (1980). 6-Keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent. Prostaglandins. 20(2). 391–400. 29 indexed citations

Miller, O.V. & Robert R. Gorman. (1979). Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.. Journal of Pharmacology and Experimental Therapeutics. 210(1). 134–140. 92 indexed citations

Gorman, Robert R., Wendell Wierenga, & O.V. Miller. (1979). Independence of the cyclic amp-lowering activity of thromboxane a2 from the platelet release reaction. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 572(1). 95–104. 40 indexed citations

Miller, O.V., et al.. (1979). Prostacyclin stimulation of dog arterial cyclic AMP levels. Prostaglandins. 18(6). 915–925. 37 indexed citations

Gorman, Robert R., F.A. Fitzpatrick, & O.V. Miller. (1977). A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2. Biochemical and Biophysical Research Communications. 79(1). 305–313. 15 indexed citations

Gorman, Robert R., Frank F. Sun, O.V. Miller, & Roy A. Johnson. (1977). Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterization. Prostaglandins. 13(6). 1043–1053. 76 indexed citations

10.

Miller, O.V., Roy A. Johnson, & Robert R. Gorman. (1977). Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane A2. Prostaglandins. 13(4). 599–609. 61 indexed citations

11.

Miller, O.V. & Robert R. Gorman. (1976). Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.. PubMed. 2(2). 79–87. 30 indexed citations

12.

Robert, André, Wayne E. Magee, O.V. Miller, & James E. Nezamis. (1974). Intestinal absorption of prostaglandin F2α, 15(S)-15-methyl prostaglandin F2α and their methyl esters in the dog. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 348(2). 269–278. 15 indexed citations

13.

Magee, Wayne E., et al.. (1973). Absorption of prostaglandins by the intestine and vagina of the rat. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 306(2). 270–282. 25 indexed citations

14.

Magee, Wayne E. & O.V. Miller. (1972). Liposomes containing Antiviral Antibody can protect Cells from Virus Infection. Nature. 235(5337). 339–341. 70 indexed citations

15.

Magee, Wayne E. & O.V. Miller. (1970). Individual Variability in Antibody Response of Human Volunteers to Infection of the Upper Respiratory Tract by Coxsackie A-21 Virus. The Journal of Infectious Diseases. 122(3). 127–138. 2 indexed citations

16.

Magee, Wayne E., et al.. (1968). Inhibition by interferon of the uncoating of vaccinia virus. Virology. 35(4). 505–511. 31 indexed citations

17.

Magee, Wayne E. & O.V. Miller. (1968). Initiation of Vaccinia Virus Infection in Actinomycin D-pretreated Cells. Journal of Virology. 2(7). 678–685. 19 indexed citations

18.

Levine, Seymour, et al.. (1967). Effect of interferon on early enzyme and viral DNA synthesis in vaccinia virus infection. Virology. 32(1). 33–40. 23 indexed citations

19.

Magee, Wayne E. & O.V. Miller. (1967). Immunological evidence for the appearance of a new DNA-polymerase in cells infected with vaccinia virus. Virology. 31(1). 64–69. 34 indexed citations

20.

Magee, Wayne E. & O.V. Miller. (1962). Dissociation of the synthesis of host and viral deoxyribonucleic acid. Biochimica et Biophysica Acta. 55(6). 818–826. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact